2022 Annual Meeting | CANCELLED: Being a Division Chief: More Challenges or More Opportunities? Conversation Corner

Date Sunday 04/03/22

Time 03:30 PM - 04:15 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Learner Engagement Center (Academic Exchange)

Director(s) Antonio M. Omuro, MD, FAAN

Topic(s) General Neurology

Learning Objectives The role of a division chief in Neurology requires not only strong academic expertise, but also clinical, managerial and leadership skills for which Neurologists may be unprepared. This discussion will focus on the challenges that current or aspiring division chiefs encounter on a daily basis and provide opportunities for exchanging ideas, solutions, education and networking.

CME Available No CME available

Program Tracks Academic

Recommended Audience Other

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:15 PM PDT	Speaker	Being Division Chief: More Challenges or More Opportunities? Antonio M. Omuro, MD, FAAN

Faculty Disclosures
Antonio M. Omuro, MD, FAAN	Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma.